Characterization of Neutralizing Anti-Drug Antibody Response in Patients With Loss of Response to Anti-TNF Therapy

被引：0
|
作者：
Hauenstein, Scott
Salbato, Jared
Lockton, Steven
Singh, Sharat
机构：
来源：
GASTROENTEROLOGY | 2013年 / 144卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S418 / S418
页数：1
相关论文
共 50 条
  • [21] Time to treatment response with abatacept in patients with RA and an inadequate response to Anti-TNF therapy
    Schiff, M.
    Dougados, M.
    Le Bars, M.
    Lafosse, C.
    Koncz, T.
    Genovese, M. C.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S307 - S308
  • [22] Predicting response to anti-TNFα therapy among patients with rheumatoid arthritis
    Hyrich, K
    Watson, K
    Symmons, D
    Silman, A
    RHEUMATOLOGY, 2005, 44 : I24 - I24
  • [23] Periodontitis Response to Anti-TNF Therapy in Ankylosing Spondylitis
    Fabri, Gisele Maria C.
    Pereira, Rosa Maria R.
    Savioli, Cynthia
    Saad, Carla G. S.
    de Moraes, Julio Cesar B.
    Siqueira, Jose Tadeu T.
    Bonfa, Eloisa
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2015, 21 (07) : 341 - 345
  • [24] Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug
    Hyrich, K. L.
    Lunt, M.
    Dixon, W. G.
    Watson, K. D.
    Symmons, D. P. M.
    RHEUMATOLOGY, 2008, 47 (07) : 1000 - 1005
  • [25] Clinical Manifestations of an Anti-Drug Antibody Response: Autoimmune Reactions
    Swanson, Steven J.
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2014, 34 (12): : 953 - 957
  • [26] Prevalence and clinical implications of anti-drug antibody formation and serum drug levels among patients with IBD receiving anti-TNF therapy: A cross-sectional study
    Alghamdi, Ahmed
    Alahmari, Mohammed
    Aljohani, Khulood
    Alanazi, Aisha
    Al Ibrahim, Bashaar
    Alshowair, Mishal
    Tawfik, Marwa
    Alghamdi, Waleed
    Alanazi, Salman
    Alzayed, Faisal
    Alghamdi, Abdullah S.
    Bawazir, Abdullah
    Alhamidi, Hussam
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2025, 31 (02):
  • [27] Presence of Anti-drug Antibodies Does Not Reduce the Efficacy of an Oral Anti-TNF Antibody in a Murine IBD Model
    Bhol, Kailash
    Erlich, Emma
    Lemos, Brenda
    Tracey, Daniel
    Hartman, Deborah
    Fox, Barbara
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S545 - S546
  • [28] Unabated type I interferon expedites B-cell autoimmunity and anti-drug antibody formation during anti-TNF therapy
    Mennella, A.
    Mylonas, A.
    Chen, J.
    Nidegger, A.
    Gilliet, M.
    Lande, R.
    Frasca, L.
    Conrad, C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (10) : S151 - S151
  • [29] EFFICACY AND SAFETY OF ABATACEPT IN PATIENTS WITH RA AND AN INADEQUATE RESPONSE TO ANTI-TNF THERAPY BY NUMBER OF PRIOR ANTI-TNF THERAPIES USED
    Schiff, M.
    Le Bars, M.
    Gaillez, C.
    Wu, G.
    Poncet, C.
    Genovese, M. C.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S29 - S30
  • [30] Clinical and cytokine response to anti-TNF antibody therapy in severe alcoholic hepatitis.
    Jalan, R
    Williams, R
    Kaser, A
    Davies, NA
    Zoller, H
    Hodges, SJ
    Graziadei, I
    Shawcross, D
    Vogel, W
    Alisa, A
    Ludwiczek, O
    Tilg, H
    HEPATOLOGY, 2001, 34 (04) : 441A - 441A
12345